Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Current Drug Targets|October 16, 2008
Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signalingJeff S Isenberg, William A Frazier, Murali C Krishna, et al.Surgery|December 17, 2008
Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signalingJeff S Isenberg, Justin B Maxhimer, Perlita Powers, et al.Annals of Surgery|April 29, 2008
Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human diseaseJeff S Isenberg, Martin J Romeo, Justin B Maxhimer, et al.The Journal of Biological Chemistry|July 13, 2006
CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1Jeff S Isenberg, Lisa A Ridnour, Julie Dimitry, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Deficit of CD47 results in a defect of marginal zone dendritic cells, blunted immune response to particulate antigen and impairment of skin dendritic cell migrationSven Hagnerud, Partha Pratim Manna, Marina Cella, et al.The Journal of Biological Chemistry|November 14, 2008
Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responsesJeff S Isenberg, Douglas S Annis, Michael L Pendrak, et al.Cancer Research|March 12, 2009
CD47 regulates bone mass and tumor metastasis to boneOzge Uluçkan, Stephanie N Becker, Hongju Deng, et al.Matrix Biology : Journal of the International Society for Matrix Biology|May 14, 2005
Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factorJ Scott Isenberg, Maria J Calzada, Longen Zhou, et al.Matrix Biology : Journal of the International Society for Matrix Biology|March 17, 2009
Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stressJeff S Isenberg, Yan Qin, Justin B Maxhimer, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 6, 2007
Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemiaJeff S Isenberg, Fuminori Hyodo, Loretta K Pappan, et al.Pageof 4